Teladoc finalizes blockbuster deal with Livongo in less than 3 months By Heather Landi Fiercehealthcare.com - Telehealth giant Teladoc completed its massive $18.5 billion acquisition of Livongo, the company announced Friday. The deal was wrapped up quickly, in under three months, as the companies likely look to leverage the current financial tailwinds of
Author: Editor
Volume 1, Issue 1: Launching Medical Travel & Digital Health News: Dr. Whitney Goldner, Professor, IM Division of Diabetes, Endocrine & Metabolism, University of Nebraska Medical Center, Discusses Advances in Digital Health
Dear Colleagues,For over a decade, Medical Travel Today has provided 40,000 readers worldwide with news, information and business perspectives on medical travel. In response to market changes prompted by COVID-19 and advanced technology, we are broadening our focus to include digital health: Medical Travel & Digital Health News not only features
Spotlight Interview: Dr. Whitney Goldner, Professor, Internal Medicine Division of Diabetes, Endocrine & Metabolism, University of Nebraska Medical Center
About Dr. Whitney Goldner Whitney Goldner, M.D., is a professor of Medicine, Division of Diabetes, Endocrinology, and Metabolism at the University of Nebraska Medical Center, Omaha, Nebraska. She is an endocrinologist and director of the Thyroid and Endocrine Tumor Program at the Fred and Pamela Buffett Cancer Center. She is also
Industry News: Volume 1, Issue 1
Tying Health Care Investment to Performance By Brian Klepper and Jeffrey Hogan Thehealthcareblog.com - GoodRx’s planned initial public offering recently made the news, notable because the company, launched in 2011, has been profitable since 2016. Evidently, it’s become unfashionable for investors to demand proof of performance, so GoodRx’s results shone like a
Volume 10, Issue 26: Pawan Saharan, Founder & CEO, Biomix Network Inc. Discusses Clinical Trials
Dear Colleagues, Medical Travel Today is excited to bring you an interview with Pawan Saharan, Founder & CEO, Biomix Network Inc., a company empowering millions of farmers & their families by procuring dairy waste to manufacturing life-saving Receptol to prevent all communicable diseases including Swine flu, HIV/AIDS, Cancer, TB, Common cold,
Spotlight Interview: Pawan Saharan, Founder & CEO, Biomix Network Inc.
About Pawan Saharan, MS, Ph.D. Founder & CEO: Biomix Network Inc. USA, India, AUS [email protected] [email protected] Whats app Mbl # +91 8291084108 Visit www.biomix.in for further information Dr. Pawan Saharan, with a vision to provide “Health for All,” invented the world’s 1st immunity enhancement drug for all communicable diseases including HIV, Swine Flue, SARS Covid and
Industry News: Volume 10, Issue 26
INDUSTRY NEWS Fixing the Biggest Problems in Healthcare Published on September 27, 2020 By Michael Gorton Teladoc founder, author, keynote speaker, serial entrepreneur. I build world changing companies from ideas. Healthcare is broken. If you believe that statement and you are building a company that should be part of the engine that fixes it, read
VOLUME 4 ISSUE 8: Mark Beeston, Vice President , Sales and Marketing, Viogaurd Discusses Killing Germs in a COVID-19 Era
Dear Colleagues, Medical Travel Today is excited to bring you an interview with Mark Beeston, Vice President, Sales and Marketing, Viogaurd, a company developing products that enhance the effectiveness of infection control strategies. In this interview, Beeston discusses using UV technology to kill germs. This issue also brings you news on digital
Spotlight Interview: Mark Beeston, Vice President, Sales and Marketing, Vioguard
About Mark Beeston Mark Beeston joined Vioguard June 2017 as vice president of Sales and Marketing. Prior to Vioguard, Beeston lead a sales team for Option Care in the post-acute business sector. He spent six years in various sales leadership roles from regional sales director to director of Strategic Solutions at
Industry News: VOLUME 4 ISSUE 9
More Consolidation, IPOs Ahead for Digital Health Companies By Fenwick & West LLP Lexology.com - Virtual healthcare staked out exciting new ground with the recently announced $18.5 billion merger of telemedicine pioneer Teladoc Health and chronic disease management company Livongo. The deal illustrates the growing appetite among public-market investors for innovative healthcare solutions. To view the